26 May 2013
Keywords: klaus, dembowsky, named, head, speedel, experimenta, swiss
Article | 27 September 2007
Swiss biotechnology firm Speedel has appointed Klaus Dembowsky as head of Speedel Experimenta, its late-stage R&D unit. Dr Dembowsky ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 October 2007
24 May 2013
© 2013 thepharmaletter.com